Copyright
©The Author(s) 2021.
World J Gastrointest Surg. Mar 27, 2021; 13(3): 267-278
Published online Mar 27, 2021. doi: 10.4240/wjgs.v13.i3.267
Published online Mar 27, 2021. doi: 10.4240/wjgs.v13.i3.267
Figure 1 Overall survival and disease-free survival in all cases.
DFS: Disease-free survival; OS: Overall survival.
Figure 2 Disease-free survival between the neoadjuvant radiochemotherapy group and neoadjuvant chemotherapy group.
NCT: Neoadjuvant chemotherapy; NRCT: Neoadjuvant radiochemotherapy.
Figure 3 Overall survival between the neoadjuvant radiochemotherapy group and neoadjuvant chemotherapy group.
NCT: Neoadjuvant chemotherapy; NRCT: Neoadjuvant radiochemotherapy.
- Citation: Li WC, Zhao JK, Feng WQ, Miao YM, Xu ZF, Xu ZQ, Gao H, Sun J, Zheng MH, Zong YP, Lu AG. Retrospective research of neoadjuvant therapy on tumor-downstaging, post-operative complications, and prognosis in locally advanced rectal cancer. World J Gastrointest Surg 2021; 13(3): 267-278
- URL: https://www.wjgnet.com/1948-9366/full/v13/i3/267.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v13.i3.267